This story was updated on January 31 at 9:32 a.m. with PharMerica's statement.
The Federal Trade Commission issued a complaint last Friday to block Omnicare, Inc.'s, hostile acquisition of rival long-term care pharmacy provider PharMerica Corporation, alleging that the combination of the two largest U.S. LTC pharmacies would harm competition.
The complaint also argues Omnicare’s attempted takeover would enable the pharmacy services provider to raise the price of drugs for Medicare Part D consumers and others.